| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Daniela Pende | Q87778985 |
| Enrico Munari | Q41496165 | ||
| Genny Del Zotto | Q56486086 | ||
| P2093 | author name string | Gabriella Pietra | |
| Lorenzo Moretta | |||
| Franco Locatelli | |||
| Massimo Vitale | |||
| Michela Falco | |||
| Claudia Cantoni | |||
| Maria Cristina Mingari | |||
| Francesca Moretta | |||
| Alice Bertaina | |||
| Chiara Vitale | |||
| P2860 | cites work | Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation | Q86063263 |
| 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells | Q87260909 | ||
| PD-L1 Expression Heterogeneity in Non-Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections | Q88500747 | ||
| PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists | Q89101546 | ||
| NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines | Q90021348 | ||
| Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board | Q90890106 | ||
| Innate Lymphoid Cells: 10 Years On | Q91127104 | ||
| Human NK cells: surface receptors, inhibitory checkpoints, and translational applications | Q91691392 | ||
| Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? | Q93139338 | ||
| Specific recognition by CD3- NK cells: a limiting dilution analysis of the frequency of alloreactive CD3- lymphocyte precursors | Q93524116 | ||
| NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily | Q22008826 | ||
| Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells | Q22010576 | ||
| Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells | Q22010724 | ||
| Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death | Q24293504 | ||
| The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions | Q24310543 | ||
| Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity | Q24310824 | ||
| Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells | Q24314176 | ||
| Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily | Q24314332 | ||
| Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule | Q24314704 | ||
| Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells | Q24315619 | ||
| Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles | Q24315770 | ||
| Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1 | Q24316372 | ||
| A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation | Q24317089 | ||
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains | Q24317666 | ||
| NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains | Q24324781 | ||
| Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes | Q24328841 | ||
| NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis | Q24647094 | ||
| p46, a novel natural killer cell-specific surface molecule that mediates cell activation | Q24647847 | ||
| Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells | Q24671834 | ||
| NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease | Q24675566 | ||
| X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells | Q24676168 | ||
| Plasticity in the organization and sequences of human KIR/ILT gene families | Q24676718 | ||
| The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer | Q24677386 | ||
| NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules | Q24679688 | ||
| Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand | Q27622806 | ||
| Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex | Q27631386 | ||
| KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C | Q27657994 | ||
| Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11 | Q27681802 | ||
| Features of Memory-Like and PD-1(+) Human NK Cell Subsets | Q28073988 | ||
| Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism | Q28201347 | ||
| Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype | Q28203016 | ||
| KIR: diverse, rapidly evolving receptors of innate and adaptive immunity | Q28203441 | ||
| Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells | Q28211347 | ||
| In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
| Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
| HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
| A human killer inhibitory receptor specific for HLA-A1,2 | Q28277216 | ||
| Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 | Q28277389 | ||
| HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1 | Q28278705 | ||
| HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors | Q28298119 | ||
| Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor | Q28304420 | ||
| Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus | Q28743897 | ||
| Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. | Q28754594 | ||
| Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. | Q29568902 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C. | Q30252783 | ||
| High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles | Q33282995 | ||
| Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity | Q33378871 | ||
| Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus | Q33580199 | ||
| Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex | Q33630659 | ||
| Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. | Q33682888 | ||
| Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles | Q33740971 | ||
| Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations | Q37240335 | ||
| qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination | Q37295082 | ||
| Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1. | Q37342417 | ||
| Location and cellular stages of natural killer cell development | Q37366117 | ||
| Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells | Q37372822 | ||
| Class I HLA haplotypes form two schools that educate NK cells in different ways | Q37415636 | ||
| Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. | Q37472014 | ||
| Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry | Q37569278 | ||
| Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution | Q37641722 | ||
| Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells | Q37729495 | ||
| Unifying concepts of MHC-dependent natural killer cell education | Q37900760 | ||
| Shaping of NK cell responses by the tumor microenvironment | Q38067641 | ||
| Impact of HCMV Infection on NK Cell Development and Function after HSCT. | Q38174881 | ||
| Effect of tumor cells and tumor microenvironment on NK-cell function. | Q38207947 | ||
| The biology of innate lymphoid cells | Q38319907 | ||
| A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. | Q38346525 | ||
| Human KIR repertoires: shaped by genetic diversity and evolution | Q38568881 | ||
| Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction | Q38568891 | ||
| The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β2-Microglobulin-Independent Ligand on Cancer Cells | Q38716300 | ||
| KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing | Q38731024 | ||
| Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion | Q38739856 | ||
| Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology | Q38744688 | ||
| Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection | Q38802522 | ||
| KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans | Q38849746 | ||
| The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay | Q38861402 | ||
| Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR | Q39401664 | ||
| Missing or altered self: human NK cell receptors that recognize HLA-C. | Q39427580 | ||
| NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs | Q39624540 | ||
| Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. | Q40191693 | ||
| Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells | Q40195850 | ||
| Human NK cell education by inhibitory receptors for MHC class I. | Q40244934 | ||
| Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients. | Q40260933 | ||
| KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand | Q40364675 | ||
| The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. | Q40609313 | ||
| Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization | Q40627446 | ||
| Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia | Q40734859 | ||
| Identification of NKp80, a novel triggering molecule expressed by human NK cells | Q40818782 | ||
| The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex | Q40898237 | ||
| Receptors for HLA class-I molecules in human natural killer cells. | Q41039762 | ||
| Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. | Q41065335 | ||
| Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells | Q41302982 | ||
| Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. | Q41339112 | ||
| KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families | Q36410876 | ||
| IPD--the Immuno Polymorphism Database. | Q36491455 | ||
| HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells | Q36738298 | ||
| Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies | Q36750477 | ||
| Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition | Q36863181 | ||
| Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand | Q36920302 | ||
| Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. | Q37153103 | ||
| Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene | Q37173270 | ||
| Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells | Q37216218 | ||
| Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 | Q73443956 | ||
| Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor | Q73481205 | ||
| The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster | Q73769951 | ||
| Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype | Q77437408 | ||
| Immunology. A perfect mismatch | Q77768910 | ||
| Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes | Q77952249 | ||
| A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain | Q79174425 | ||
| KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro | Q80582168 | ||
| Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments | Q81248308 | ||
| Dissecting CD56dim human NK cells | Q82431129 | ||
| Molecular characterisation of KIR2DS2*005, a fusion gene associated with a shortened KIR haplotype | Q84143627 | ||
| Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. | Q41356549 | ||
| KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C. | Q41930029 | ||
| P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie | Q42045430 | ||
| Influence of KIR gene copy number on natural killer cell education | Q42142698 | ||
| Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity | Q42152584 | ||
| Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood | Q42242376 | ||
| Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes | Q42614259 | ||
| Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn | Q42938918 | ||
| The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. | Q43746260 | ||
| Innate immunity: The unsung heroes | Q45963435 | ||
| The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF. | Q46435322 | ||
| Licensing of natural killer cells by host major histocompatibility complex class I molecules | Q46634172 | ||
| Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. | Q47074403 | ||
| PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability | Q47115697 | ||
| Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System. | Q47140967 | ||
| The Broad Spectrum of Human Natural Killer Cell Diversity | Q47373461 | ||
| Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. | Q47431117 | ||
| Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. | Q47431127 | ||
| IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. | Q47599849 | ||
| Cutting edge: expansion of the KIR locus by unequal crossing over | Q47677728 | ||
| Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature | Q48787037 | ||
| Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned | Q49351739 | ||
| Natural killer cell education in human health and disease | Q50137212 | ||
| CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. | Q51990042 | ||
| Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. | Q52805676 | ||
| The ILC World Revisited. | Q52840755 | ||
| KIR genotyping by reverse sequence-specific oligonucleotide methodology. | Q53572784 | ||
| Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients. | Q55294325 | ||
| Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education | Q56875357 | ||
| Alessandro Moretta 1953–2018 | Q56942098 | ||
| Natural killer cell specificity for viral infections | Q56966491 | ||
| Novel multiplex PCR-SSP method for centromeric KIR allele discrimination | Q57023127 | ||
| IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma | Q57172150 | ||
| NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia | Q59360645 | ||
| Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups | Q59624583 | ||
| Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells | Q60302404 | ||
| Design and Validation of a Multiplex KIR and HLA Class I Genotyping Method Using Next Generation Sequencing | Q60947062 | ||
| CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor | Q61719162 | ||
| Education of human natural killer cells by activating killer cell immunoglobulin-like receptors | Q61905881 | ||
| Analysis ofKIR3DP1Polymorphism Provides Relevant Information on CentromericKIRGene Content | Q61953734 | ||
| 2B4 functions as a co-receptor in human NK cell activation | Q61953855 | ||
| Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? | Q63257349 | ||
| The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules | Q72646538 | ||
| Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination | Q73299848 | ||
| Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells | Q73369937 | ||
| Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering | Q33932618 | ||
| Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors | Q33947906 | ||
| The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition | Q34105279 | ||
| Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. | Q34155492 | ||
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. | Q34178128 | ||
| The genomic context of natural killer receptor extended gene families | Q34341455 | ||
| Genetic and functional relationships between MHC and NK receptor genes | Q34376850 | ||
| Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells | Q34452527 | ||
| CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. | Q34572976 | ||
| Recombinant structures expand and contract inter and intragenic diversification at the KIR locus | Q34581495 | ||
| Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans | Q34807762 | ||
| The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. | Q35030951 | ||
| NK-CTLs, a novel HLA-E-restricted T-cell subset | Q35077159 | ||
| The IPD and IMGT/HLA database: allele variant databases | Q35254060 | ||
| Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response | Q35744664 | ||
| Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population | Q35751442 | ||
| HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. | Q35798486 | ||
| Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function | Q35849347 | ||
| KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding | Q35864564 | ||
| Different checkpoints in human NK-cell activation | Q35941923 | ||
| MHC class I molecules and KIRs in human history, health and survival | Q36047157 | ||
| A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma. | Q36070261 | ||
| Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes | Q36075234 | ||
| Influence of KIR diversity on human immunity | Q36148911 | ||
| Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function | Q36181155 | ||
| Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans | Q36231084 | ||
| Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) | Q36231811 | ||
| Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors | Q36285376 | ||
| Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors | Q36300377 | ||
| A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function | Q36350702 | ||
| Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells | Q36351997 | ||
| Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture | Q36355739 | ||
| The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor | Q36364603 | ||
| Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule | Q36366692 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | hematopoietic stem cell transplantation | Q1128050 |
| P304 | page(s) | 1179 | |
| P577 | publication date | 2019-05-28 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation | |
| P478 | volume | 10 |
| Q98614786 | A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions |
| Q90557658 | Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry |
| Q103805662 | Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients |
| Q90193343 | NK Cells as Potential Targets for Immunotherapy in Endometriosis |
| Q91936162 | Summer School in Flow Cytometry for Immunology: Report From a Successful ESCCA Experience |
| Q97883506 | Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy |
| Q98465673 | The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation |
| Q90176787 | Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy? |
| Q96431447 | Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria |
Search more.